Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 6

Results: 39

Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia.
Published in:
2008
By:
- Ball, L.;
- Bredius, R.;
- Lankester, A.;
- Schweizer, J.;
- Van Den Heuvel-Eibrink, M.;
- Escher, H.;
- Fibbe, W.;
- Egeler, M.
Publication type:
Letter
Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells.
Published in:
2008
By:
- Kong, G.;
- Wang, D.;
- Wang, H.;
- Wu, J.;
- Bielawski, J.;
- Konopleva, M.;
- Andreeff, M.;
- Ruvolo, P. P.;
- Maurer, B. J.
Publication type:
Letter
T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.
Published in:
2008
By:
- Schneider, B.;
- Nagel, S.;
- Kaufmann, M.;
- Winkelmann, S.;
- Bode, J.;
- Drexler, H. G.;
- MacLeod, R. A. F.
Publication type:
Letter
BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia.
Published in:
2008
By:
- Larmonie, N. S. D.;
- Dik, W. A.;
- Beverloo, H. B.;
- Van Wering, E. R.;
- Van Dongen, J. J. M.;
- Langerak, A. W.
Publication type:
Case Study
The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
Published in:
2008
By:
- Remstein, E. D.;
- Law, M.;
- Mollejo, M.;
- Piris, M. A.;
- Kurtin, P. J.;
- Dogan, A.
Publication type:
Letter
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.
Published in:
2008
By:
- Tamai, H.;
- Shioi, Y.;
- Yamaguchi, H.;
- Okabe, M.;
- Wakita, S.;
- Mizuki, T.;
- Nakayama, K.;
- Inokuchi, K.;
- Tajika, K.;
- Dan, K.
Publication type:
Case Study
MicroRNA expression profiles of human leukemias.
Published in:
2008
By:
- Takada, S.;
- Yamashita, Y.;
- Berezikov, E.;
- Hatanaka, H.;
- Fujiwara, S.-i.;
- Kurashina, K.;
- Watanabe, H.;
- Enomoto, M.;
- Soda, M.;
- Choi, Y. L.;
- Mano, H.
Publication type:
Letter
Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.
Published in:
2008
By:
- Soler, G.;
- Radford-Weiss, I.;
- Ben-abdelali, R.;
- Mahlaoui, N.;
- Ponceau, J. F.;
- Macintyre, E. A.;
- Vekemans, M.;
- Bernard, O. A.;
- Romana, S. P.
Publication type:
Letter
Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients.
Published in:
2008
By:
- Mazumder, A.;
- Kaufman, J.;
- Niesvizky, R.;
- Lonial, S.;
- Vesole, D.;
- Jagannath, S.
Publication type:
Letter
Reply to ‘Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients’.
Published in:
2008
By:
- Kumar, S.;
- Gertz, M. A.
Publication type:
Letter
Use of pegylated recombinant filgrastim (Pegfilgrastim) in patients with acute myeloid leukemia: pharmacokinetics and impact on leukocyte recovery.
Published in:
2008
By:
- Fiegl, M.;
- Hiddemann, W.;
- Braess, J.
Publication type:
Letter
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML.
Published in:
2008
By:
- Liso, A.;
- Bogliolo, A.;
- Freschi, V.;
- Martelli, M. P.;
- Pileri, S. A.;
- Santodirocco, M.;
- Bolli, N.;
- Martelli, M. F.;
- Falini, B.
Publication type:
Letter
JAK2 Mutations are present in all cases of polycythemia vera.
Published in:
2008
By:
- Wang, Y. L.;
- Vandris, K.;
- Jones, A.;
- Cross, N. C. P.;
- Christos, P.;
- Adriano, F.;
- Silver, R. T.
Publication type:
Letter
Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy.
Published in:
2008
By:
- Steiner, M.;
- Attarbaschi, A.;
- Haas, O. A.;
- Kastner, U.;
- Gadner, H.;
- Mann, G.
Publication type:
Letter
Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
Published in:
2008
By:
- Véronèse, L.;
- Tournilhac, O.;
- Verrelle, P.;
- Davi, F.;
- Dighiero, G.;
- Chautard, E.;
- Veyrat-Masson, R.;
- Kwiatkowski, F.;
- Goumy, C.;
- Vago, P.;
- Travade, P.;
- Tchirkov, A.
Publication type:
Letter
Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes.
Published in:
2008
By:
- Benetatos, L.;
- Dasoula, A.;
- Syed, N.;
- Hatzimichael, E.;
- Crook, T.;
- Bourantas, K. L.
Publication type:
Letter
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
Published in:
2008
By:
- Atallah, E.;
- Nussenzveig, R.;
- Yin, C. C.;
- Bueso-Ramos, C.;
- Tam, C.;
- Manshouri, T.;
- Pierce, S.;
- Kantarjian, H.;
- Verstovsek, S.
Publication type:
Letter
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.
Published in:
2008
By:
- Paripati, H.;
- Stewart, A. K.;
- Cabou, S.;
- Dueck, A.;
- Zepeda, V. J.;
- Pirooz, N.;
- Ehlenbeck, C.;
- Reeder, C.;
- Slack, J.;
- Leis, J. F.;
- Boesiger, J.;
- Torloni, A. S.;
- Fonseca, R.;
- Bergsagel, P. L.
Publication type:
Letter
Globalization of treatment strategies in leukemia: challenges and responsibilities.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1093, doi. 10.1038/leu.2008.132
By:
- Tefferi, A.;
- Killmann, N. M.-B.
Publication type:
Article
T-cell receptor Vβ CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1170, doi. 10.1038/leu.2008.23
By:
- De Vries, A. C. H.;
- Langerak, A. W.;
- Verhaaf, B.;
- Niemeyer, C. M.;
- Stary, J.;
- Schmiegelow, K.;
- Van Wering, E. R.;
- Zwaan, C. M.;
- Beishuizen, A.;
- Pieters, R.;
- Van Den Heuvel-Eibrink, M. M.
Publication type:
Article
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.
Published in:
2008
By:
- Fabbri, M.;
- Garzon, R.;
- Andreeff, M.;
- Kantarjian, H. M.;
- Garcia-Manero, G.;
- Calin, G. A.
Publication type:
journal article
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1175, doi. 10.1038/leu.2008.49
By:
- Matarraz, S.;
- López, A.;
- Barrena, S.;
- Fernandez, C.;
- Jensen, E.;
- Flores, J.;
- Bárcena, P.;
- Rasillo, A.;
- Sayagues, J. M.;
- Sánchez, M. L.;
- Hernandez-Campo, P.;
- Rivas, J. M. Hernandez;
- Salvador, C.;
- Fernandez-Mosteirín, N.;
- Giralt, M.;
- Perdiguer, L.;
- Orfao, A.
Publication type:
Article
Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1154, doi. 10.1038/leu.2008.52
By:
- Baak, U.;
- Gökbuget, N.;
- Orawa, H.;
- Schwartz, S.;
- Hoelzer, D.;
- Thiel, E.;
- Burmeister, T.
Publication type:
Article
AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1241, doi. 10.1038/leu.2008.53
By:
- Takeshita, M.;
- Ichikawa, M.;
- Nitta, E.;
- Goyama, S.;
- Asai, T.;
- Ogawa, S.;
- Chiba, S.;
- Kurokawa, M.
Publication type:
Article
HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1161, doi. 10.1038/leu.2008.57
By:
- Whelan, J. T.;
- Ludwig, D. L.;
- Bertrand, F. E.
Publication type:
Article
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation.
Published in:
2008
By:
- Zhao, W.;
- Gu, Y. H.;
- Song, R.;
- Qu, B. Q.;
- Xu, Q.
Publication type:
journal article
Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1125, doi. 10.1038/leu.2008.59
By:
- Habib, A.;
- Hamade, E.;
- Mahfouz, R.;
- Nasrallah, M. S.;
- De Thé, H.;
- Bazarbachi, A.
Publication type:
Article
RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1131, doi. 10.1038/leu.2008.60
By:
- Futami, M.;
- Hatano, T.;
- Soda, Y.;
- Kobayashi, S.;
- Miyagishi, M.;
- Tojo, A.
Publication type:
Article
Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1144, doi. 10.1038/leu.2008.63
By:
- Karachunskiy, A.;
- Herold, R.;
- Von Stackelberg, A.;
- Miakova, N.;
- Timakow, A.;
- Mahortih, T.;
- Bajdun, L.;
- Maschan, A.;
- Fechina, L.;
- Shamardina, A.;
- Dudkin, S.;
- Lebedev, V.;
- Varfolomeeva, S.;
- Timofeeva, V.;
- Roumiantseva, J.;
- Chipsanova, N.;
- Rumjanzew, A.;
- Henze, G.
Publication type:
Article
Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1184, doi. 10.1038/leu.2008.65
By:
- Sherbenou, D. W.;
- Hantschel, O.;
- Turaga, L.;
- Kaupe, I.;
- Willis, S.;
- Bumm, T.;
- Press, R. D.;
- Superti-Furga, G.;
- Druker, B. J.;
- Deininger, M. W.
Publication type:
Article
Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1214, doi. 10.1038/leu.2008.67
By:
- Kamath, M. B.;
- Houston, I. B.;
- Janovski, A. J.;
- Zhu, X.;
- Gowrisankar, S.;
- Jegga, A. G.;
- DeKoter, R. P.
Publication type:
Article
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1234, doi. 10.1038/leu.2008.68
By:
- Cilloni, D.;
- Messa, F.;
- Rosso, V.;
- Arruga, F.;
- Defilippi, I.;
- Carturan, S.;
- Catalano, R.;
- Pautasso, M.;
- Panuzzo, C.;
- Nicoli, P.;
- Messa, E.;
- Morotti, A.;
- Iacobucci, I.;
- Martinelli, G.;
- Bracco, E.;
- Saglio, G.
Publication type:
Article
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism.
Published in:
2008
By:
- Zhang, H.;
- Trachootham, D.;
- Lu, W.;
- Carew, J.;
- Giles, F. J.;
- Keating, M. J.;
- Arlinghaus, R. B.;
- Huang, P.
Publication type:
journal article
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
Published in:
2008
By:
- Feldman, A. L.;
- Sun, D. X.;
- Law, M. E.;
- Novak, A. J.;
- Attygalle, A. D.;
- Thorland, E. C.;
- Fink, S. R.;
- Vrana, J. A.;
- Caron, B. L.;
- Morice, W. G.;
- Remstein, E. D.;
- Grogg, K. L.;
- Kurtin, P. J.;
- Macon, W. R.;
- Dogan, A.
Publication type:
journal article
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1106, doi. 10.1038/leu.2008.79
By:
- Chiarini, F.;
- Del Sole, M.;
- Mongiorgi, S.;
- Gaboardi, G. C.;
- Cappellini, A.;
- Mantovani, I.;
- Follo, M. Y.;
- McCubrey, J. A.;
- Martelli, A. M.
Publication type:
Article
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.
Published in:
2008
By:
- Quintás-Cardama, A.;
- Tong, W.;
- Manshouri, T.;
- Vega, F.;
- Lennon, P. A.;
- Cools, J.;
- Gilliland, D. G.;
- Lee, F.;
- Cortes, J.;
- Kantarjian, H.;
- Garcia-Manero, G.;
- Quintás-Cardama, A
Publication type:
journal article
CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1207, doi. 10.1038/leu.2008.83
By:
- Kong, Y.;
- Yoshida, S.;
- Saito, Y.;
- Doi, T.;
- Nagatoshi, Y.;
- Fukata, M.;
- Saito, N.;
- Yang, S. M.;
- Iwamoto, C.;
- Okamura, J.;
- Liu, K. Y.;
- Huang, X. J.;
- Lu, D. P.;
- Shultz, L. D.;
- Harada, M.;
- Ishikawa, F.
Publication type:
Article
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
Published in:
2008
By:
- Hochhaus, A.;
- Baccarani, M.;
- Deininger, M.;
- Apperley, J. F.;
- Lipton, J. H.;
- Goldberg, S. L.;
- Corm, S.;
- Shah, N. P.;
- Cervantes, F.;
- Silver, R. T.;
- Niederwieser, D.;
- Stone, R. M.;
- Dombret, H.;
- Larson, R. A.;
- Roy, L.;
- Hughes, T.;
- Müller, M. C;
- Ezzeddine, R.;
- Countouriotis, A. M.;
- Kantarjian, H. M.
Publication type:
journal article
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1250, doi. 10.1038/leu.2008.88
By:
- Schilling, G.;
- Hansen, T.;
- Shimoni, A.;
- Zabelina, T.;
- Simon-Perez, J.-A.;
- Gutierrez, N. C.;
- Bethge, W.;
- Liebisch, P.;
- Schwerdtfeger, R.;
- Bornhäuser, M.;
- Otterstetter, S.;
- Penas, E. M. M.;
- Dierlamm, J.;
- Ayuk, F.;
- Atanackovic, D.;
- Bacher, U.;
- Bokemeyer, C.;
- Zander, A.;
- Miguel, J. S.;
- Nagler, A.
Publication type:
Article

Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 6

Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia.

Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells.

T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.

BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia.

The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.

Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.

MicroRNA expression profiles of human leukemias.

Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.

Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients.

Reply to ‘Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients’.

Use of pegylated recombinant filgrastim (Pegfilgrastim) in patients with acute myeloid leukemia: pharmacokinetics and impact on leukocyte recovery.

In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML.

JAK2 Mutations are present in all cases of polycythemia vera.

Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy.

Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.

Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes.

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.

Globalization of treatment strategies in leukemia: challenges and responsibilities.

T-cell receptor Vβ CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.

MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34<sup>+</sup> hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.

AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.

HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.

Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation.

Arsenic trioxide inhibits ATRA-induced prostaglandin E<sub>2</sub> and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia.

RNAi-mediated silencing of p190<sup>Bcr-Abl</sup> inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190<sup>Bcr-Abl</sup>-expressing leukemia cells.

Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.

Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations.

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism.

Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.

The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.

CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.